Cooper Companies | COO - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Abbott USD 297M 2M 2026-09
Align Technology USD 9.96M 3.02M 2026-06
AtriCure USD 1.2M 15K 2026-06
Bausch Health Companies USD 398M 2M 2026-09
Baxter International USD 64M 14M 2026-06
Bayer EUR 675M 87M 2025-12
Becton, Dickinson and Co. USD 130M 2M 2026-09
Boston Scientific USD 100M 4M 2026-09
Cooper Companies USD 21.5M 600K 2026-06
Dentsply International USD 27M 5M 2026-09
Dexcom USD 3.1M 100K 2026-09
Edwards Lifesciences USD 30M 5.9M 2026-06
Globus Medical USD 5.53B 39.93M 2026-09
Haemonetics USD 5.08M 2.32M 2026-03
Inogen 1.03M 384K 2025-03
Insulet USD 12.3M 1.3M 2026-09
Integra LifeSciences USD 22.96M 33K 2026-09
Intuitive Surgical USD 19.35B 1.53B 2026-09
J&J USD 43M 25M 2026-03
Medtronic USD 186M 10M 2026-06
Merit Medical Systems USD 7.33M 4.78M 2026-09
Novartis USD 281M 8M 2025-09
ResMed USD 8.79M 14.55M 2025-09
STAAR Surgical USD 900K 100K 2026-06
Steris USD 11.2M 4.6M 2026-09
Stryker USD 47.25B 683M 2026-09
Tandem Diabetes Care USD 1.16B 5.29M 2026-09
Teleflex USD 21.21M 6.75M 2026-09
Zimmer Biomet Holdings USD 23.54B 740.8M 2026-09